CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a peer-to-peer computing framework for efficient molecular simulations in drug design. By enabling users to run complex workflows on personal devices, it aims to streamline the process of calculating free energies and enhance accessibility in the pharmaceutical industry.
Computational chemistry is playing an increasingly important role for research in the pharmaceutical industry, oils & plastic, and materials development.
Simulation and high-throughput screening can be orders of magnitude cheaper than experiments in the early stages of drug design.
The ERC project preceding this application has developed several new techniques that make it orders-of-magnitude more efficient to calculate free energies from simulations rather than approximate docking screening.
We…
SERENDIPITY INNOVATIONS AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, STOCKHOLM
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
